RumbleOn (NASDAQ:RMBL – Free Report) had its target price cut by B. Riley from $9.00 to $7.00 in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock.
Separately, Wedbush lowered their target price on RumbleOn from $7.00 to $5.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th.
Read Our Latest Analysis on RMBL
RumbleOn Stock Performance
Institutional Trading of RumbleOn
Large investors have recently made changes to their positions in the stock. Rhumbline Advisers boosted its stake in shares of RumbleOn by 3,910.5% during the 2nd quarter. Rhumbline Advisers now owns 19,772 shares of the company’s stock worth $81,000 after acquiring an additional 19,279 shares in the last quarter. Virtu Financial LLC bought a new stake in shares of RumbleOn during the 1st quarter worth about $90,000. Dimensional Fund Advisors LP boosted its stake in shares of RumbleOn by 35.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 29,182 shares of the company’s stock worth $120,000 after acquiring an additional 7,704 shares in the last quarter. Magnus Financial Group LLC bought a new stake in shares of RumbleOn during the 2nd quarter worth about $127,000. Finally, Bank of New York Mellon Corp bought a new stake in shares of RumbleOn during the 2nd quarter worth about $182,000. Institutional investors own 66.14% of the company’s stock.
RumbleOn Company Profile
RumbleOn, Inc primarily operates as a powersports retailer in the United States. It operates in two segments, Powersports and Vehicle Transportation Services. The Powersports segment provides new and pre-owned motorcycles, all-terrain vehicles, utility terrain or side-by-side vehicles, personal watercraft, snowmobiles, and other powersports products.
Further Reading
- Five stocks we like better than RumbleOn
- Pros And Cons Of Monthly Dividend Stocks
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- Business Services Stocks Investing
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- The Most Important Warren Buffett Stock for Investors: His Own
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Receive News & Ratings for RumbleOn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RumbleOn and related companies with MarketBeat.com's FREE daily email newsletter.